Synthesis of Tetrasubstituted Furan Derivatives
(CH3), 24.35 (CH2), 29.56 (CH3), 41.30 (CH2), 51.95 (CH3), 66.33 2849 (w), 1704 (vs), 1578 (w), 1425 (w), 1281 (m), 1174 (m), 1096
(CH2), 124.17 (C), 127.94 (CH), 128.07 (2 CH), 128.39 (2 CH),
132.87 (C), 136.76 (C), 139.48 (C), 156.46 (C), 159.44 (C), 160.49 236 (33) [M+], 193 (100), 175 (36), 140 (38), 105 (22), 91 (29).
(C), 194.39 (C) ppm. IR (ATR): ν = 3363 (w), 2920 (w), 2851 (w),
HRMS (ESI, pos. mode): calcd. for C14H21O3 [M + H+] 237.1491;
(vs), 1079 (vs), 982 (w), 784 (w) cm–1. MS (EI, 70 eV): m/z (%) =
˜
1706 (vs), 1525 (w), 1412 (w), 1331 (w), 1243 (m), 1160 (w), 903 found 237.1494.
(m), 733 (s) cm–1. HRMS (ESI, pos. mode): calcd. for
3-Isopropyl 8a-Methyl 2-Methyl-5,6,7,8-tetrahydro-8aH-cyclohepta-
[b]furan-3,8a-dicarboxylate (5b): H NMR (500 MHz, CDCl3): δ =
C19H21NNaO6 [M + Na+] 382.1267; found 382.1267.
1
1.23 (d, J = 6.2 Hz, 6 H), 1.37–1.49 (m, 1 H), 1.71–1.83 (m, 3 H),
1.92–2.02 (m, 1 H), 2.19–2.24 (m, 2 H), 2.26 (s, 3 H), 2.29–2.33 (m,
1 H), 3.79 (s, 3 H), 5.11 (sept, J = 6.2 Hz, 1 H), 6.51 (t, J = 7.1 Hz,
1 H) ppm. 13C{1H} NMR (125 MHz, CDCl3): δ = 15.43 (CH3),
22.06 (2 CH3), 26.62 (CH2), 27.67 (CH2), 28.04 (CH2), 34.29 (CH2),
52.62 (CH3), 67.15 (CH), 93.26 (C), 107.03 (C), 120.35 (CH),
Methyl 4-Acetyl-3-(2-acetamidoethyl)-5-methylfuran-2-carboxylate
(6b): A mixture of piperidone 1g (250 mg, 1.16 mmol), acetyl-
acetone (2a; 581 mg, 5.81 mmol) and CeCl3·7H2O (43 mg,
0.11 mmol) in AcOH (1.2 mL) was stirred at 80 °C for 1 d. After
filtration and removal of the solvent under reduced pressure the
crude product was purified by column chromatography (SiO2,
CH2Cl2/MeOH, 10:1, Rf = 0.35) to yield title compound 6b (86%,
267 mg, 1.00 mmol) as a colorless resin. 1H NMR (500 MHz,
CDCl3): δ = 1.87 (s, 3 H), 2.51 (s, 3 H), 2.66 (s, 3 H), 3.19 (t, J =
6.0 Hz, 2 H), 3.49 (q, J = 5.4 Hz, 2 H), 3.91 (s, 3 H), 6.45 (br. s, 1
H) ppm. 13C{1H} NMR (125 MHz, CDCl3): δ = 15.90 (CH3),
23.15 (CH3), 23.60 (CH2), 31.07 (CH3), 40.41 (CH2), 52.09 (CH3),
124.33 (C), 133.25 (C), 139.44 (C), 159.59 (C), 160.51 (C), 170.26
140.53 (C), 164.16 (C), 169.22 (C), 170.82 (C) ppm. IR (ATR): ν =
˜
2979 (w), 2930 (m), 2852 (w), 1742 (s), 1695 (vs), 1618 (s), 1445
(w), 1395 (m), 1267 (w), 1199 (s), 1141 (m), 1093 (vs), 997 (s) cm–1.
MS (EI, 70 eV): m/z (%) = 294 (13) [M+], 235 (31), 193 (100), 175
(64), 147 (10), 91 (22), 77 (18). HRMS (ESI, pos. mode): calcd. for
C16H23O5 [M + H+] 295.1545; found 295.1555.
Methyl
3-Acetyl-2-oxo-4,5,6,7,8,8a-hexahydrocyclohepta[b]furan-
(C), 194.78 (C) ppm. IR (ATR): ν = 3300 (w), 2952 (w), 2361 (w),
8a-carboxylate (8): 1H NMR (500 MHz, CDCl3): δ = 1.21–1.29 (m,
1 H), 1.50–1.61 (m, 2 H), 1.67–1.77 (m, 2 H), 1.89–1.99 (m, 1 H),
2.12–2.16 (m, 1 H), 2.46–2.51 (m, 2 H), 2.57 (s, 3 H), 3.40–3.45 (m,
1 H), 3.78 (s, 3 H) ppm. 13C{1H} NMR (125 MHz, CDCl3): δ =
23.05 (CH2), 28.01 (CH2), 28.75 (CH2), 29.82 (CH2), 30.20 (CH3),
33.46 (CH2), 53.68 (CH3), 89.98 (C), 124.32 (C), 167.65 (C), 169.90
˜
1715 (s), 1667 (vs), 1601 (w), 1538 (m) 1436 (s), 1412 (m), 1360 (w),
1329 (w), 1245 (m), 1067 (m), 647 (m) cm–1. HRMS (EI, 70 eV):
calcd. for C13H17NO5 [M+] 267.1107; found 267.1101.
Ethyl 4-Acetyl-3-(2-acetoxyethyl)-5-methylfuran-2-carboxylate (6c):
A mixture of pyrancarboxylate 1h (162 mg, 0.860 mmol), acetyl-
acetone (2a; 430 mg, 4.30 mmol) and CeCl3·7H2O (32 mg,
0.086 mmol) in AcOH (0.9 mL) was stirred at ambient temperature
for 14 d. After filtration and removal of the solvent under reduced
pressure the crude product was purified by column chromatog-
raphy (SiO2, hexane/MTBE, 1:2, Rf = 0.37) to yield title compound
6c (74%, 180 mg, 0.640 mmol) as a colorless oil. 1H NMR
(500 MHz, CDCl3): δ = 1.36 (t, J = 7.1 Hz, 3 H), 1.96 (s, 3 H),
2.47 (s, 3 H), 2.63 (s, 3 H), 3.36 (t, J = 6.7 Hz, 2 H), 4.23 (t, J =
6.7 Hz, 2 H), 4.35 (q, J = 7.1 Hz, 2 H) ppm. 13C{1H} NMR
(125 MHz, CDCl3): δ = 14.24 (CH3), 15.68 (CH3), 20.83 (CH3),
24.08 (CH2), 30.96 (CH3), 60.99 (CH2), 63.52 (CH2), 124.19 (C),
131.01 (C), 139.84 (C), 158.88 (C), 160.25 (C), 170.72 (C), 193.93
(C), 179.88 (C), 194.34 (C) ppm. IR (ATR): ν = 2935 (w), 2857
˜
(w), 2935 (w), 1766 (vs), 1739 (vs), 1620 (m), 1446 (w), 1364 (m),
1253 (m), 1241 (s), 1009 (s) cm–1. MS (EI, 70 eV): m/z (%) = 252
(3) [M+], 220 (8), 210 (16), 193 (71), 151 (100), 123 (34), 95 (48).
HRMS (ESI, pos. mode): calcd. for C13H16NaO5 [M + Na+]
275.0895; found 275.0887.
Supporting Information (see footnote on the first page of this arti-
1
cle): H and 13C{1H} NMR spectra of all products.
Acknowledgments
The authors are grateful to Marc Schmidtmann for X-ray crystal-
lography. Miriam Penning is thanked for data processing.
(C) ppm. IR (ATR): ν = 2981 (w), 1737 (vs), 1711 (vs), 1671 (m),
˜
1602 (w), 1413 (m), 1367 (w), 1235 (vs), 1155 (vs), 1099 (w), 1066
(m), 1037 (s), 960 (w), 773 (w) cm–1. HRMS (EI, 70 eV): calcd. for
C14H18O6 [M+] 282.1103; found 282.1093.
[1] For reviews, see: a) S. O. Simonetti, E. L. Larghi, A. B. J.
Bracca, T. S. Kaufman, Nat. Prod. Rep. 2013, 30, 941–969; b)
M. R. Shaaban, A. H. M. Elwahy, Curr. Org. Synth. 2013, 10,
425–466; c) P. Vitale, A. Scilimati, Curr. Org. Chem. 2013, 17,
1986–2000; d) M. Negwer, H.-G. Scharnow, Organic-Chemical
Drugs and Their Synonyms, 8th ed., Wiley-VCH, Weinheim,
Germany, 2001.
[2] a) C. R. Reddy, M. D. Reddy, J. Org. Chem. 2014, 79, 106–116;
b) Y.-T. Lee, Y.-T. Lee, C.-J. Lee, C.-N. Sheu, B.-Y. Lin, J.-H.
Wang, W. Lin, Org. Biomol. Chem. 2013, 11, 5156–5161; c) S.
Dhiman, S. S. V. Ramasastry, J. Org. Chem. 2013, 78, 10427–
10436; d) L. K. Sydnes, R. Isanov, M. Sengee, F. Livi, Synth.
Commun. 2013, 43, 2898–2905; e) S. R. Mothe, S. J. L. Lauw, P.
Kothandaraman, P. W. H. Chan, J. Org. Chem. 2012, 77, 6937–
6947; f) W.-Y. Huang, Y.-C. Chen, K. Chen, Chem. Asian J.
2012, 7, 688–691.
Reaction of Cyclic β-Oxo Ester 1d with Isopropyl Acetoacetate (2c):
A mixture of cyclic β-oxo ester 1d (186 mg, 1.00 mmol), isopropyl
acetoacetate (2c; 721 mg, 5.00 mmol) and CeCl3·7H2O (37.0 mg,
0.100 mmol) in AcOH (1 mL) was stirred at 100 °C for 40 h. After
filtration and removal of the solvent under reduced pressure the
product mixture was separated by column chromatography (SiO2,
hexane/MTBE, 5:1) to yield, as the first fraction, title compound
4g (33%, 77 mg, 0.33 mmol, Rf = 0.68) as yellow oil. The second
fraction containing compound 5b (6%, 18 mg, 0.060 mmol, Rf =
0.37) was eluted as a colorless liquid. Finally, the last fraction con-
tained compound 8 (10%, 28 mg, 0.10 mmol, Rf = 0.11) as a color-
less oil.
Isopropyl
2-Methyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]furan-3-
[3] a) C. Song, L. Ju, M. Wang, P. Liu, Y. Zhang, J. Wang, Z. Xu,
Chem. Eur. J. 2013, 19, 3584–3589; b) C. Song, S. Dong, L.
Feng, X. Peng, M. Wang, J. Wang, Z. Xu, Org. Biomol. Chem.
2013, 11, 6258–6262; c) A. N. Butkevich, L. Meerpoel, I. Stans-
field, P. Angibaud, A. Corbu, J. Cossy, Org. Lett. 2013, 15,
3840–3843; d) Y. Xia, S. Qu, Q. Xiao, Z.-X. Wang, P. Qu, L.
Chen, Z. Liu, L. Tian, Z. Huang, Y. Zhang, J. Wang, J. Am.
Chem. Soc. 2013, 135, 13502–13511; e) B. Yin, H. Yu, Z. Li,
carboxylate (4g): 1H NMR (500 MHz, CDCl3): δ = 1.31 (d, J =
6.2 Hz, 6 H), 1.65–1.72 (m, 4 H), 1.73–1.78 (m, 2 H), 2.46 (s, 3 H),
2.69 (t, J = 5.7 Hz, 2 H), 2.77 (t, J = 5.7 Hz, 2 H), 5.15 (sept, J =
6.2 Hz, 1 H) ppm. 13C{1H} NMR (125 MHz, CDCl3): δ = 14.26
(CH3), 22.09 (2 CH3), 23.88 (CH2), 26.24 (CH2), 28.23 (CH2), 28.34
(CH2), 30.53 (CH2), 66.99 (CH), 114.03 (C), 121.11 (C), 151.83 (C),
155.73 (C), 164.60 (C) ppm. IR (ATR): ν = 2978 (w), 2922 (m),
˜
Eur. J. Org. Chem. 2014, 4410–4416
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4415